Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,389 | 47,102 | 30,186 | 34,382 | 41,001 |
| Receivables | 119,636 | 118,544 | 136,295 | 132,185 | 143,018 |
| Inventories | 96,276 | 87,953 | 84,766 | 76,952 | 69,078 |
| Other current assets | 0 | 37,873 | 2,777 | 0 | 0 |
| TOTAL | $260,638 | $308,664 | $272,575 | $271,082 | $277,157 |
| Non-Current Assets | |||||
| PPE Net | 41,862 | 36,556 | 27,456 | 26,643 | 25,112 |
| Investments And Advances | 6,539 | 2,620 | 2,621 | 13,033 | 78,486 |
| Intangibles | 512,685 | 523,501 | 647,313 | 1,070,960 | 809,679 |
| Other Non-Current Assets | 15,238 | 16,063 | 422,684 | 16,304 | 18,342 |
| TOTAL | $576,324 | $578,740 | $1,100,074 | $1,126,940 | $931,619 |
| Total Assets | $836,962 | $887,404 | $1,372,649 | $1,398,022 | $1,208,776 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,320 | 41,320 | 33,056 | 31,302 | 22,547 |
| Accounts payable and accrued liabilities | 41,364 | 32,828 | 36,697 | 19,075 | 25,735 |
| Accrued Expenses | 121,748 | 115,769 | 111,570 | 116,890 | 146,758 |
| Other current liabilities | 4,672 | 6,146 | 122,694 | 121,106 | 3,833 |
| TOTAL | $179,104 | $196,063 | $304,017 | $288,373 | $198,873 |
| Non-Current Liabilities | |||||
| Long Term Debt | 374,568 | 404,265 | 385,010 | 393,102 | 351,433 |
| Other Non-Current Liabilities | 50,999 | 81,660 | 282,095 | 215,554 | 40,150 |
| TOTAL | $424,517 | $450,979 | $656,410 | $730,503 | $489,713 |
| Total Liabilities | $603,621 | $647,042 | $960,427 | $1,018,876 | $688,586 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,580 | 78,273 | 78,054 | 77,739 | 77,451 |
| Common Shares | 79 | 79 | 78 | 80 | 80 |
| Retained earnings | -308,137 | -304,456 | -165,306 | -133,376 | -25,131 |
| Other shareholders' equity | 50,801 | 52,264 | 86,874 | 34,409 | 71,445 |
| TOTAL | $233,341 | $240,362 | $412,222 | $379,146 | $520,190 |
| Total Liabilities And Equity | $836,962 | $887,404 | $1,372,649 | $1,398,022 | $1,208,776 |